P

Inventor

HORNSPERGER BENOIT

FR34 patents
⚠️ This page may combine multiple inventors who share the name “HORNSPERGER BENOIT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

30 patents
US10035804B2Jul 31, 2018

Spirodiamine derivatives as aldosterone synthase inhibitors

HOFFMANN LA ROCHE10 citations82
US11420961B2Aug 23, 2022

Heterocyclic compounds

HOFFMANN LA ROCHE6 citations74
US9695151B2Jul 4, 2017

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

HOFFMANN LA ROCHE6 citations73
US9695152B2Jul 4, 2017

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

HOFFMANN LA ROCHE6 citations73
US11981661B2May 14, 2024

Heterocyclic compounds

HOFFMANN LA ROCHE2 citations72
US11814375B2Nov 14, 2023

Heterocyclic compounds

HOFFMANN LA ROCHE2 citations72
US10428108B2Oct 1, 2019

Difluoroketamide derivatives

HOFFMANN LA ROCHE5 citations72
US9980929B2May 29, 2018

Trifluoromethylpropanamide derivatives

HOFFMANN LA ROCHE5 citations72
US9505742B2Nov 29, 2016

3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

HOFFMANN LA ROCHE4 citations72
US11802133B2Oct 31, 2023

Heterocyclic compounds as monoacylglycerol lipase inhibitors

HOFFMANN LA ROCHE2 citations71
US11608347B2Mar 21, 2023

Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors

HOFFMANN LA ROCHE4 citations71
US11390610B2Jul 19, 2022

Piperazine derivatives as MAGL inhibitors

HOFFMANN LA ROCHE6 citations71
US9187429B2Nov 17, 2015

Phenyl-tetrahydroisoquinoline derivatives

HOFFMANN LA ROCHE2 citations62
US12281124B2Apr 22, 2025

Heterocyclic compounds as monoacylglycerol lipase inhibitors

HOFFMANN LA ROCHE0 citations60
US11001555B2May 11, 2021

Difluoroketamide derivatives as HTRA1 inhibitors

HOFFMANN LA ROCHE0 citations52
US11059858B2Jul 13, 2021

Difluoroketamide derivatives as HtrA1 inhibitors

HOFFMANN LA ROCHE0 citations51
US11014963B2May 25, 2021

Trifluoromethylpropanamide derivatives as HTRA1 inhibitors

HOFFMANN LA ROCHE0 citations51
US12577257B2Mar 17, 2026

Heterocyclic compounds

HOFFMANN LA ROCHE0 citations50
US10870623B2Dec 22, 2020

Trifluoromethylpropanamide derivatives as HTRA1 inhibitors

HOFFMANN LA ROCHE0 citations41
US10865182B2Dec 15, 2020

Difluoroketamide derivatives as HtrA1 inhibitors

HOFFMANN LA ROCHE0 citations41
US9796726B2Oct 24, 2017

Dihydroquinoline pyrazolyl compounds

HOFFMANN LA ROCHE0 citations41
US9796702B2Oct 24, 2017

Dihydroquinoline pyrazolyl compounds

HOFFMANN LA ROCHE0 citations41
US9790217B2Oct 17, 2017

Pyridinyloxy- and phenyloxy-pyrazolyl compounds

HOFFMANN LA ROCHE0 citations41
US9790200B2Oct 17, 2017

Dihydroquinoline pyrazolyl compounds

HOFFMANN LA ROCHE0 citations41
US9636339B2May 2, 2017

Phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors

HOFFMANN LA ROCHE0 citations41
US9636338B2May 2, 2017

Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthase

HOFFMANN LA ROCHE0 citations41
US9593107B2Mar 14, 2017

Dihydroquinoline-2-one derivatives

HOFFMANN LA ROCHE0 citations41
US9464058B2Oct 11, 2016

Imidazolylketone derivatives

HOFFMANN LA ROCHE0 citations41
US9458135B2Oct 4, 2016

Dihydroquinoline-2-one derivatives

HOFFMANN LA ROCHE0 citations41
US9133158B2Sep 15, 2015

Bicyclic dihydroisoquinoline-1-one derivatives

HOFFMANN LA ROCHE0 citations41

AEBI JOHANNES

2 patents

NOVARTIS AG

1 patent

BANNER DAVID

1 patent